Fig 4. Overexpression of ATOH1 reduced the in vivo tumorigenicity of GCSCs and of NCI-N87 gastric cancer cells in the subcutaneous injection (A, B, C) and liver metastasis model (D).

After 4 weeks, the tumor masses were obtained and their weights measured (C).